Ключевые слова:
юрак ишемик касаллиги, ADIPOR2, A219T, адипонектин рецептори, генетик полиморфизм, прогноз, генетик хавф.Библиографические ссылки
1. Ralapanawa U., Sivakanesan R. Epidemiology and the Magnitude of Coronary Artery Disease and Acute Coronary Syndrome: A Narrative Review. J Epidemiol Glob Health. 2021;11(2):169–177.
2. Miyazawa K., Ito K. Genetic Analysis for Coronary Artery Disease Toward Diverse Populations. Front Genet. 2021;12:766485.
3. Wang H., Liu Z., Shao J. et al. Pathogenesis of premature coronary artery disease: Focus on risk factors and genetic variants. Genes & Diseases. 2020;9(2):370–380.
4. Yusuf S., Joseph P., Rangarajan S. et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 countries (PURE): a prospective cohort study. Lancet. 2020; 395(10226):795–808.
5. Gumanova N.G., Gavrilova N.E., Chernushevich O.I. et al. Ratios of leptin to insulin and adiponectin to endothelin are sex-dependently associated with extent of coronary atherosclerosis. Biomarkers. 2017;22(3-4):239–245.
6. Hou H., Ge S., Zhao L. et al. An updated systematic review and meta-analysis of association between adiponectin gene polymorphisms and coronary artery disease. OMICS. 2017;21(6):340–351.
7. Akan G., Görmez S., Atalar F. et al. Association of ADIPOQ gene variants and circulating adiponectin levels with coronary artery disease risk. Cyprus J Med Sci. 2026;11(1):40–47.
8. Medina-Leyte D.J., Zepeda-García O., Domínguez-Pérez M. et al. Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches. Int J Mol Sci. 2021;22(8):3850.
